Get emergency medical help immediately if you have signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or···【Read More】
Update: 2026-02-26Source: Haiou HealthViews: 91
Grapefruit may interact with Exkivity and cause side effects.Avoid eating grapefruit or drinking grapefruit juice products while taking this medicine.【Read More】
Update: 2026-02-26Source: Haiou HealthViews: 92
Take the missed dose as soon as you remember. However, if it has been more than 6 hours since your scheduled dose, skip the missed dose. Do not take t···【Read More】
Update: 2026-02-26Source: Haiou HealthViews: 92
Mobotinib is an oral targeted therapy primarily used to treat locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring specific gen···【Read More】
Update: 2026-02-26Source: Haiou HealthViews: 93
Mobocertinib is a targeted therapy for EGFRexon20 insertion-mutated non-small cell lung cancer. Common side effects include diarrhea, rash, stomatitis···【Read More】
Update: 2026-02-26Source: Haiou HealthViews: 91
The price of mobotinib after reimbursement under China's national medical insurance varies depending on the specific circumstances. Choosing the g···【Read More】
Update: 2026-02-26Source: Haiou HealthViews: 88
The specific price of Mobocertinib is currently affected by the purchase channel, regional policies, and medical insurance reimbursement. This drug mu···【Read More】
Update: 2026-02-26Source: Haiou HealthViews: 90
Acalabrutinib is a vital targeted therapy for leukemia and lymphoma, with its price fluctuations and clinical guidelines remaining a focus of medical ···【Read More】
Update: 2026-02-26Source: Haiou HealthViews: 99
Acalabrutinib is a critical targeted therapy for leukemia and lymphoma, and the reliability of your purchase channel directly impacts treatment outcom···【Read More】
Update: 2026-02-26Source: Haiou HealthViews: 101
Acalabrutinib is used for adult patients with:chronic lymphocytic leukemia (CLL)small lymphocytic lymphoma (SLL)mantle cell lymphoma (MCL) patientswho···【Read More】
Update: 2026-02-26Source: Haiou HealthViews: 101
Cancer cells get signals to grow and divide from a protein called Bruton tyrosine kinase (BTK). Acalabrutinib mechanism of action is by blocking BTK t···【Read More】
Update: 2026-02-26Source: Haiou HealthViews: 98
October 31, 2017 -- The U.S. Food and Drug Administration today granted accelerated approval to Calquence (acalabrutinib) for the treatment of adults ···【Read More】
Update: 2026-02-26Source: Haiou HealthViews: 100
21 November 2019 -- AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved Calquence (acalabrutinib) for adult patien···【Read More】
Update: 2026-02-26Source: Haiou HealthViews: 96
17 January 2025 -- AstraZeneca’s Calquence (acalabrutinib) in combination with bendamustine and rituximab has been approved in the US for the treatmen···【Read More】
Update: 2026-02-26Source: Haiou HealthViews: 98
Key Advantages of the New Tablet Formulation- New formulation can be co-administered with gastric acid-reducing agents- Tablet offers equivalent effic···【Read More】
Update: 2026-02-26Source: Haiou HealthViews: 101
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos



